... the agreement. As such, there are negative implications for poor people's access to life-saving drugs. So it can be said that affordability is one of the factors restricting access, and patent protection is a key issue influencing the affordability of new drugs. QUESTION 4: The 2001 Doha Declaration was an important step forward in this campaign for affordable medicines, is Oxfam satisfied with the suggested improvements? At Doha the primacy of public health superceeded intellectual property rights, and the rights of governments to make full use of the safeguards in TRIPS was affirmed, however, it was also recognized that fundamental imbalances exist within the TRIPS agreement. Until these imbalances are worked out, affordable medicines are not in reach for those most in need. QUESTION 3: Does Oxfam consider the protocol outlined by TRIPS on the production of cheaper generic drugs, balanced or imbalanced? The TRIPS agreement in terms of generic drug production is imbalanced. Many ...

See this essay or coursework document in full right now